Overview
Join a Heart Failure Prevention Research Study
Researchers are evaluating investigational treatments for Heart Failure Prevention. Take our pre-screener to see if you qualify for an ongoing research study.
About this Study
This study is looking at ways to prevent heart failure in people who are at higher risk. Heart failure happens when the heart doesn’t pump blood as well as it should, which can lead to serious health problems over time.
Researchers are studying a combination of Baxdrostat and Dapagliflozin to see if it can better reduce the risk of heart failure and heart-related deaths compared with taking Dapagliflozin alone. Some participants may receive a placebo to help researchers compare the results.
The main goal of this study is to understand whether adding Baxdrostat to standard treatment can improve heart health and lower the chances of developing heart failure.
By participating, you can help researchers find better ways to protect people at risk of heart problems.
Who Can Join
You may be able to participate if you:
- Are 40 years or older
- Have Type 2 diabetes and are receiving treatment for it
- Do not currently have heart failure
- Do not have liver or kidney disease
You may NOT be eligible if you:
- Take certain medications that could interfere with the study, such as some immunosuppressants, heart or kidney medications, or herbal supplements like St. John’s Wort
- Have other medical conditions that may affect your safety in the study
Not sure if you qualify? A member of our study team will review your medical history and medications with you to determine if this study may be a good fit.
Why You Should Join
Heart failure is a serious condition that can be life-threatening. By joining this research study, you’re not just a participant; you’re a vital contributor to the search for potential new treatments.
-
Advance Medical Knowledge: Help us advance Heart Failure Prevention medical research and contribute to the search for potential new treatments.
-
Be a Partner: By joining, you’re not just a participant; you’re a partner in developing new Heart Failure Prevention treatments.
-
Innovative Approach: Help researchers test a potential new Heart Failure Prevention treatment.
What to Expect
Study Duration:
Approximately 3.5 years
Study Visits:
There will be 15 visits throughout the study
Compensation:
Participants may receive up to $1,425 for their time and participation
Procedures During the Study:
You will take the study medication as directed and attend scheduled check-ins.
You may have routine health assessments, lab tests, and other procedures to track heart health.